490
Participants
Start Date
September 2, 2013
Primary Completion Date
October 5, 2018
Study Completion Date
October 5, 2018
Meloxicam 15 mg po QD
Eligible subjects will be take Meloxicam 15 mg po QD
Cognitive Behavioral Therapy
Subjects originally assigned to placebo will receive cognitive behavioral therapy for 10 weeks
VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven
North Florida/South Georgia Veterans Health System, Gainesville, FL, Gainesville
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Providence VA Medical Center, Providence, RI, Providence
VA Office of Research and Development
FED